Research.Patient.info
Non-Muscle-Invasive Bladder Cancer (NMIBC) research hub
2 indexed studies · 0 currently recruiting
- recruitingPhase III
HIVEC® HEAT - the drug mitomycin medac will be warmed to 43°C and administered through a catheter into the bladder via HIVEC® device for patients with nonmuscle-invasive bladder cancer that have previously had no response to BCG treatment
This study looks at a new way to treat bladder cancer that hasn't responded to usual treatment. It uses a warmed drug, mitomycin medac, delivered directly into the bladder to help people avoid bladder removal surgery.
United Kingdom · England - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) and Pembrolizumab in Combination with Other Investigational Agents in Subjects with High-risk Non-muscle-Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy
This study is looking at new treatments for a type of early bladder cancer that hasn't responded to usual therapy. We are testing medicines like pembrolizumab (Keytruda) alone or with other drugs to see if they can help patients whose cancer is considered high-risk.
Finland · Greece · Netherlands